Visitor preview: 5 stories per pageCreate a free account to read 10 stories per page and get 1 free in-depth AI investigation. Create my free account
Events database
Merck/Moderna cancer vaccine cuts risk of melanoma death or recurrence by over 40%
Advanced analysis (spheres, detailed sources, paid analyses)
Event date
exact date
Coverage
11 outlets · 11 articles
first · latest
Reporting countries
Brazil, United Kingdom, Greece, Mexico, Portugal +1
Greek, English, Spanish, Portuguese
Countries concerned
United States
Health · intensity 1.0 · tone -0.67
In 5 seconds
Covered mainly by the Western sphere (73%); silent in Arab-Muslim world.
Western 73%Sino-Russian & BRICS 18%Arab-Muslim world 0%Global South 9%
Global sphere reading. The left / centre / right reading is shown in the coverage analysis below.
In 30 seconds
- Confirmed by 11 outlets in 6 countries.
- Ignored by Arab-Muslim world.
- Propagation: first reported by srnnews.com (Portugal), . 4 outlets republished 2 headlines word for word.
Headline clash across the four spheres
Western
- Merck/Moderna cancer vaccine cuts risk of melanoma death or recurrence by over 40%srnnews.com · Portugal
- Merck/Moderna cancer vaccine cuts risk of death or recurrence from melanoma by over 40% reut.rs/4dRUKdJReuters (Bluesky) · United Kingdom
Sino-Russian & BRICS
- Vacina contra câncer reduz em 42% risco de morte ou recidiva de melanomaFolha de S.Paulo · Brazil
- Vacina contra câncer reduz em 42% risco de morte ou recidiva de melanomaUOL · Brazil
Arab-Muslim world
No outlet in this sphere covers the event: blind spot.
Global South
- Vacuna contra el cáncer reduciría 42% el riesgo de muerteelpueblo.com · Mexico
Coverage analysis
Analyzing coverage…
Event sources
- Merck/Moderna cancer vaccine cuts risk of melanoma death or recurrence by over 40%srnnews.comPortugalPortugal → United StatesEnglish
- Merck/Moderna cancer vaccine cuts risk of death or recurrence from melanoma by over 40% reut.rs/4dRUKdJReuters (Bluesky)Royaume-UniUnited Kingdom → United KingdomEnglish
- Cancer Vaccine Cuts the Risk of Melanoma Recurrence, Merck and Moderna ReportThe New York TimesÉtats-UnisUnited States → United StatesEnglish
- Reuters: Moderna και Merck ανακοινώνουν ότι το εξατομικευμένο εμβόλιο κατά του καρκίνου μείωσε κατά 42% τον κίνδυνο θανάτου ή υποτροπής για το μελάνωμαiefimerida.grGRGreece → Unknown countryGreek
- mRNA cancer vaccine slashes melanoma death or recurrence risk by 42%the-independent.comUnknownUnited Kingdom → United KingdomEnglish
- mRNA cancer vaccine slashes melanoma death or recurrence risk by 42%The IndependentRoyaume-UniUnited Kingdom → United KingdomEnglish
- Merck/Moderna cancer vaccine cuts melanoma death or recurrence risk by 42%, shares fallca.finance.yahoo.comUnknownUnited Kingdom → United StatesEnglish
- Vacuna contra el cáncer reduciría 42% el riesgo de muerteelpueblo.comMXMexico → United StatesSpanish
- A Personalized Cancer Vaccine Lowers Melanoma Recurrence by 42%time.comUnknownUnited States → United StatesEnglish
- Vacina contra câncer reduz em 42% risco de morte ou recidiva de melanomaFolha de S.PauloBrésilBrazil → BrazilPortuguese
- Vacina contra câncer reduz em 42% risco de morte ou recidiva de melanomaUOLBrésilBrazil → Unknown countryPortuguese